{"id":"W4402321108","doi":"10.1186/s12943-024-02098-5","title":"Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance","year":2024,"lang":"en","type":"article","venue":"Molecular Cancer","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Agencia Estatal de Investigación; Erasmus+; European Regional Development Fund; Institut Gustave-Roussy; Cancéropôle Ile de France; Ligue Contre le Cancer; Ministerio de Ciencia e Innovación; Institut Universitaire de France; Fondation pour la Recherche Médicale; Association pour la Recherche sur le Cancer; Seerave Foundation; Agence Nationale de la Recherche; European Research Council; Ministerio de Ciencia, Innovación y Universidades; Institut National Du Cancer; Alliance Nationale pour les Sciences de la Vie et de la Santé; China Scholarship Council; Xunta de Galicia; Mark Foundation For Cancer Research","keywords":"Immunosurveillance; Biology; Cofactor; Cancer; Internal medicine; Endocrinology; Cancer research; Biochemistry; Medicine; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001405248,0.0002613091,0.000265173,0.0000936911,0.00007984885,0.00006704919,0.0001661465,0.0002126199,0.00008932016],"category_scores_gemma":[0.00009005763,0.0002417079,0.0001322561,0.0001937301,0.0001010713,0.00001812776,0.00009408899,0.0001533035,0.00000131127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007331454,"about_ca_system_score_gemma":0.0002225887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002703562,"about_ca_topic_score_gemma":0.0001540167,"domain_scores_codex":[0.998571,0.00007856824,0.0002581719,0.000602507,0.0001580987,0.0003316269],"domain_scores_gemma":[0.9993474,0.00001693399,0.0001127717,0.000296569,0.0001126262,0.0001137111],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001341461,0.00003965853,0.005096008,0.0002035677,0.000263404,0.000003243083,0.0001345016,0.00001976093,0.9742112,0.00001793225,0.000471458,0.01940515],"study_design_scores_gemma":[0.0004731452,0.0003095306,0.0004126694,0.000181459,0.00003962971,0.000001912128,0.00002546797,0.000137626,0.9740034,0.0000229363,0.02408919,0.0003030231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.96969,0.02588994,0.001019075,0.0001486791,0.0003422426,0.0007767848,0.002086332,0.00003792079,0.000009080045],"genre_scores_gemma":[0.9936689,0.002585111,0.0005711798,0.0000592604,0.0002901701,0.002585209,0.00004778165,0.00008366283,0.0001087103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02397897,"threshold_uncertainty_score":0.9856561,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0125555654376791,"score_gpt":0.2952544036050793,"score_spread":0.2826988381674002,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}